Form 8-K - Current report:
SEC Accession No. 0001023024-24-000063
Filing Date
2024-05-23
Accepted
2024-05-23 16:06:03
Documents
15
Period of Report
2024-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20240521.htm   iXBRL 8-K 61986
2 EX-10.2 exhibit102formofrestricted.htm EX-10.2 42810
3 EX-10.3 exhibit103formofrestricted.htm EX-10.3 45346
  Complete submission text file 0001023024-24-000063.txt   294051

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20240521.xsd EX-101.SCH 1874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20240521_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20240521_pre.xml EX-101.PRE 12491
18 EXTRACTED XBRL INSTANCE DOCUMENT ani-20240521_htm.xml XML 2690
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 24978171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)